Cargando…

β-Lactam Therapeutic Drug Monitoring in Critically Ill Patients: Weighing the Challenges and Opportunities to Assess Clinical Value

OBJECTIVE: β-lactams are the cornerstone of empiric and targeted antibiotic therapy for critically ill patients. Recently, there have been calls to use β-lactam therapeutic drug monitoring (TDM) within 24–48 hours after the initiation of therapy in critically ill patients. In this article, we review...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dilworth, Thomas J., Schulz, Lucas T., Micek, Scott T., Kollef, Marin H., Rose, Warren E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259115/ https://www.ncbi.nlm.nih.gov/pubmed/35815181 http://dx.doi.org/10.1097/CCE.0000000000000726

Ejemplares similares

Weighing trees with lasers: advances, challenges and opportunities
por: Disney, M. I., et al.
Publicado: (2018)

Pathogen-Negative Sepsis—An Opportunity for Antimicrobial Stewardship
por: Lockhart, Gabriel C, et al.
Publicado: (2019)

2586. Comparison of Antimicrobial Regimens for Critically Ill Patients with Suspected or Confirmed Hospital-Acquired or Ventilator-Associated Pneumonia: A Retrospective, Cohort Study
por: Kosharek, Abigail, et al.
Publicado: (2023)

The Current Status and Future Perspectives of Beta-Lactam Therapeutic Drug Monitoring in Critically Ill Patients
por: Novy, Emmanuel, et al.
Publicado: (2023)

Eliminating viral hepatitis in the COVID-19 era: weighing challenge and opportunity
por: The Lancet Gastroenterology & Hepatology
Publicado: (2020)

Update on Therapeutic Drug Monitoring of Beta-Lactam Antibiotics in Critically Ill Patients—A Narrative Review
por: Stašek, Jan, et al.
Publicado: (2023)

Antibiotics for the critically ill: more than just selecting appropriate initial therapy
por: Kollef, Marin H
Publicado: (2013)

The Value of Weighing Patients
Publicado: (1911)

Treatment of gram - positive infections in critically ill patients
por: Vazquez-Guillamet, Cristina, et al.
Publicado: (2014)

Weighing risks and benefits of stress ulcer prophylaxis in critically ill patients
por: Chanpura, Trupesh, et al.
Publicado: (2012)

What’s New in Critical Illness and Injury Science? Weighing the evidence for dexmedetomidine dosing in critically ill patients with obesity
por: Hejal, Rana, et al.
Publicado: (2023)

Beta-Lactam Antibiotic Therapeutic Drug Monitoring in Critically Ill Patients: A Systematic Review and Meta-Analysis
por: Pai Mangalore, Rekha, et al.
Publicado: (2022)

318. Beta-lactam Therapeutic Drug Monitoring Improves Attainment of Target Drug Levels in Critically Ill Patients
por: Ausman, Sara, et al.
Publicado: (2023)

Antimicrobial stewardship programs: mandatory for all ICUs
por: Kollef, Marin H, et al.
Publicado: (2012)

Bacterial and fungal superinfections in critically ill patients with COVID-19
por: Bassetti, Matteo, et al.
Publicado: (2020)

Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review
por: Sime, Fekade Bruck, et al.
Publicado: (2012)

Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection
por: Novy, Emmanuel, et al.
Publicado: (2020)

743. Implementation of Beta-Lactam Therapeutic Drug Monitoring Programs in the Critically Ill: A Multicenter Mixed-Methods Study
por: Ausman, Sara, et al.
Publicado: (2022)

Assessment of risk factors for inappropriate empiric antibiotic therapy in patients with Gram-negative sterile site infection complicated by sepsis or septic shock
por: Micek, Scott, et al.
Publicado: (2017)

Beta-lactam antibiotics in continuous infusion in critically ill patients
por: Jeurissen, Axel, et al.
Publicado: (2010)

Assessment of Micronutrient Status in Critically Ill Children: Challenges and Opportunities
por: Dao, Duy T., et al.
Publicado: (2017)

Provider perspectives on beta-lactam therapeutic drug monitoring programs in the critically ill: a protocol for a multicenter mixed-methods study
por: Barreto, Erin F., et al.
Publicado: (2021)

Broad-spectrum β-lactams in obese non-critically ill patients
por: Hites, M, et al.
Publicado: (2014)

Continuous beta-lactam infusion in critically ill patients: the clinical evidence
por: Abdul-Aziz, Mohd H, et al.
Publicado: (2012)

The clinical application of beta-lactam antibiotic therapeutic drug monitoring in the critical care setting
por: Pai Mangalore, Rekha, et al.
Publicado: (2023)

Bench-to-bedside review: Understanding the impact of resistance and virulence factors on methicillin-resistant Staphylococcus aureus infections in the intensive care unit
por: Skrupky, Lee P, et al.
Publicado: (2009)

Augmented renal clearance is not a risk factor for mortality in Enterobacteriaceae bloodstream infections treated with appropriate empiric antimicrobials
por: Burnham, Jason P., et al.
Publicado: (2017)

Lack of pathogen identification influencing antibiotic de-escalation in hospital-acquired pneumonia
por: Bittmann, Matthew C., et al.
Publicado: (2022)

Impact of antibacterials on subsequent resistance and clinical outcomes in adult patients with viral pneumonia: an opportunity for stewardship
por: Crotty, Matthew P., et al.
Publicado: (2015)

Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams
por: Gonçalves-Pereira, Joao, et al.
Publicado: (2011)

An institutional perspective on the impact of recent antibiotic exposure on length of stay and hospital costs for patients with gram-negative sepsis
por: Micek, Scott, et al.
Publicado: (2012)

Characteristics and outcomes among a hospitalized patient cohort with Streptococcus pneumoniae infection
por: Micek, Scott T., et al.
Publicado: (2020)

A Case-Control Study Assessing the Impact of Nonventilated Hospital-Acquired Pneumonia on Patient Outcomes
por: Micek, Scott T., et al.
Publicado: (2016)

Weigh-In
por: Carter, Marianne
Publicado: (2016)

The weighing
por: Mema, Briseida, et al.
Publicado: (2021)

Setting the Beta-Lactam Therapeutic Range for Critically Ill Patients: Is There a Floor or Even a Ceiling?
por: Barreto, Erin F., et al.
Publicado: (2021)

Prospective Nasal Screening for Methicillin-Resistant Staphylococcus aureus in Critically Ill Patients With Suspected Pneumonia
por: Raush, Nicholas, et al.
Publicado: (2021)

718 Predictors of Hospital Mortality Among Septic ICU Patients With Acinetobacter spp. Bacteremia: A Cohort Study
por: Shorr, Andrew F., et al.
Publicado: (2014)

1658 C. difficile Recurrence is a Strong Predictor of 30-day Rehospitalization Among ICU Patients
por: Zilberberg, Marya D., et al.
Publicado: (2014)

1008. Cluster Analysis to Define Distinct Clinical Phenotypes Among Septic Patients With Bloodstream Infections
por: Guillamet, M Cristina Vazquez, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9ov6fa830sv9v31oq8c43n6scq